Medical instrumentation and technology supplier Thermo Fisher Scientific (NYSE: TMO; Waltham, MA) will acquire biotechnology company Life Technologies (NASDAQ: LIFE; Carlsbad, CA) for approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year-end 2012).
Related: Life Technologies acquires Advanced Microscopy Group
The transaction, which was approved by both companiesâ boards of directors, will enable faster results for life sciences customers working in proteomics, genomics, and cell biology.
Life Technologies provides products and services to customers conducting scientific research and genetic analysis, as well as those in applied markets, such as forensics and food safety testing. With 2012 revenues of $3.8 billion, its comprehensive offering includes reagents, consumables, instruments, and systems.
The transaction is expected to close early in 2014 and is subject to closing conditions, including regulatory approvals.
Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn
Subscribe now to BioOptics World magazine; it's free!